Ключевые слова:
Parkinson kasalligi, sitokinlar, TNF-α, IL-6, IL-10, immunologik tahlil, neyroinflamatsiyaБиблиографические ссылки
Tysnes OB, Storstein A. Epidemiology of Parkinson's disease. J Neural Transm (Vienna). 2017; 124(8):901–905.
Tansey MG, Romero-Ramos M. Immune system responses in Parkinson’s disease. Semin Immunopathol. 2019;41(1):115–128.
Hirsch EC, Standaert DG. Ten Unsolved Questions About Neuroinflammation in Parkinson’s Disease. Mov Disord. 2021;36(1):16–24.
Nagatsu T, Sawada M. Inflammatory process in Parkinson’s disease. Neurotox Res. 2005;10 (1):19–31.
Qin L, Liu Y, Wang T, et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem. 2004;279(2):1415–1421.
Blandini F. Neuroinflammation and Parkinson's disease: current knowledge and future directions. Parkinsonism Relat Disord. 2010;16(2): S80–S84.
Reale M, Iarlori C, Thomas A, et al. Peripheral cytokines profile in Parkinson’s disease. Brain Behav Immun. 2009;23(1):55–63.
Williams-Gray CH, Wijeyekoon R, Yarnall AJ, et al. Serum immune markers and disease progression in an incident Parkinson’s disease cohort (ICICLE-PD). Mov Disord. 2016;31(7):995–1003.
Chen H, O'Reilly EJ, Schwarzschild MA, Ascherio A. Peripheral inflammatory biomarkers and risk of Parkinson’s disease. Am J Epidemiol. 2008;16 7(1):90–95.
Brochard V, Combadière B, Prigent A, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182–192.